References
Akinyemiju T, Meng Q, Vin-Raviv N. Association between body mass index and in-hospital outcomes: analysis of the nationwide inpatient database. Medicine (Baltimore). 2016;95(28):e4189. doi:10.1097/MD.0000000000004189.
Chan DS, Vieira AR, Aune D, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901–14. doi:10.1093/annonc/mdu042.
Demark-Wahnefried W, Platz EA, Ligibel JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomark Prev. 2012;21(8):1244–59. doi:10.1158/1055-9965.EPI-12-0485.
Doleman B, Mills KT, Lim S, et al. Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis. Tech Coloproctol. 2016;20(8):517–35. doi:10.1007/s10151-016-1498-3.
Nagle CM, Dixon SC, Jensen A, et al. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. Br J Cancer. 2015;113(5):817–26. doi:10.1038/bjc.2015.245.
Aguilar M, Bhuket T, Torres S, et al. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313(19):1973–4. doi:10.1001/jama.2015.4260.
Ogden CL, Carroll MD, Fryar CD, et al. Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief. 2015;219:1–8.
Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81. doi:10.1016/S0140-6736(14)60460-8.
Apovian CM, Shah SN, Wolfe BM, et al. Two-year outcomes of vagal nerve blocking (vBloc) for the treatment of obesity in the ReCharge trial. Obes Surg. 2016; doi:10.1007/s11695-016-2325-7.
Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex—linking immunity and metabolism. Nat Rev Endocrinol. 2012;8(12):743–54. doi:10.1038/nrendo.2012.189.
Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579–91. doi:10.1038/nrc1408.
Hale M, Itani F, Buchta CM, et al. Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2. PLoS One. 2015;10(3):e0118784. doi:10.1371/journal.pone.0118784.
James BR, Tomanek-Chalkley A, Askeland EJ, et al. Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth. J Immunol. n189(3):1311–21. doi:10.4049/jimmunol.1100587.
Acknowledgements
This research was supported by grant 5-R25-CA47888, Cancer Prevention and Control Training Program grant, funded by the National Cancer Institute, National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
The authors declare that this article does not contain any studies performed by any of the authors involving human participants or animals.
Informed Consent
Does not apply.
Rights and permissions
About this article
Cite this article
Boi, S.K., Moore, J.X., Royston, K.J. et al. Letter to the Editor: Vagal Blocking (vBloc) Therapy: a New Era of Clinical Therapy for Extreme Obesity. OBES SURG 27, 483–484 (2017). https://doi.org/10.1007/s11695-016-2484-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-016-2484-6